Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2001
05/16/2001EP1098878A1 Bispiperidines as antithrombotic agents
05/16/2001EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions
05/16/2001EP1098644A1 Substituted benzimidazole antiviral agents
05/16/2001EP1070041A4 Phosphate-mediated cyclization
05/16/2001EP0883618B1 Difluorophenyl pyrimidyl pyridine derivatives and the use thereof in liquid crystal mixtures
05/16/2001EP0882719B1 Arylethenesulfonamide derivatives and drug composition containing the same
05/16/2001EP0843666B1 4-substituted 5-polycyclylpyrimidine herbicides
05/16/2001CN1295572A Salt of paroxetine
05/16/2001CN1295571A PDE IV inhibiting pyridine derivatives
05/16/2001CN1295570A N-pyriconyl herbicides
05/16/2001CN1295563A 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists
05/16/2001CN1295561A N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres
05/16/2001CN1295072A New polycyclic system compound as neurotransmitter release reinforcer in treatment of identification fault and derivatives thereof
05/16/2001CN1295065A Phenyl heterocyclic compound used as epoxy enzyme -2 inhibitor
05/15/2001US6232475 Reacting a substituted bromobenzene with n-vinylimide; catalytic hydrogenation
05/15/2001US6232342 Protease inhibitors
05/15/2001US6232336 Nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same
05/15/2001US6232335 2,4-Dioxopyrrolidine and 2,4-dioxotetrahydrofan derivatives and medicines containing the same at the active ingredient
05/15/2001US6232321 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
05/15/2001US6232314 Arylalkylpiperazine compounds as antioxidants
05/15/2001US6232309 2-chloropyridine or 2-chlorothiazole derivatives of heterocyclic compounds used as pesticides
05/15/2001US6232307 2-phenyl-1-(4-(2-aminoethoxy)-benzyl)-indole compounds useful as estrogenic agents
05/15/2001US6232300 Administering as hepatitis b viricide
05/15/2001US6232271 1-Methyl-5-alkylsulfonyl-, 1-methyl-5-alkylsulfinyl- and 1-methyl-5-alkylthio- substituted pyrazolylpyrazoles, processes for their preparation and their use as herbicides
05/15/2001US6231887 Drugs of pyranone derivatives
05/15/2001CA2238978C Retroviral protease inhibiting compounds
05/15/2001CA2043763C Enantiomerically selective biocatalyzed acylation
05/10/2001WO2001032656A1 Polymorphic form of a tachykinin receptor antagonist
05/10/2001WO2001032655A2 Quinoline and naphthyridine carboxylic acid antibacterials
05/10/2001WO2001032654A2 Novel heterocyclic compounds and their use as medicines
05/10/2001WO2001032653A1 Heterocyclic substituted pyrazolones
05/10/2001WO2001032649A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
05/10/2001WO2001032648A1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof
05/10/2001WO2001032647A2 Benz`f!indoles for use in the treatment of 5ht receptor related disorders
05/10/2001WO2001032646A2 Sulfonamide derivatives
05/10/2001WO2001032634A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
05/10/2001WO2001032633A1 Substituted 5-benzyl-2,4-diaminopyrimidines
05/10/2001WO2001032625A1 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
05/10/2001WO2001032619A1 Positive modulators of nicotinic receptor agonists
05/10/2001WO2001032604A1 Activators of soluble guanylate cyclase
05/10/2001WO2001032174A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists
05/10/2001DE19954229A1 New epothilone derivatives, useful for treating malignant tumors such as ovarian, stomach, colon, breast and lung carcinoma, acute lymphocytic and myelocytic leukemia and chronic inflammatory diseases such as psoriasis
05/10/2001CA2389807A1 Heterocyclic substituted pyrazolones
05/10/2001CA2389773A1 Activators of soluble guanylate cyclase
05/10/2001CA2389377A1 Substituted 5-benzyl-2,4-diaminopyrimidines
05/10/2001CA2389259A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists
05/10/2001CA2389234A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
05/10/2001CA2388202A1 Polymorphic form of a tachykinin receptor antagonist
05/10/2001CA2387745A1 Positive modulators of nicotinic receptor agonists
05/10/2001CA2387613A1 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them
05/09/2001EP1097932A1 Substituted aminoquinazolinone (thione) derivatives or salts thereof, intermediates thereof, and pest controllers and a method for using the same
05/09/2001EP1097711A2 Treatment of pulmonary hypertension
05/09/2001EP1097382A2 Imidazoline receptor binding compounds
05/09/2001EP1097142A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
05/09/2001EP1097138A1 Pharmaceutical compositions comprising 2-quinolones
05/09/2001CN1294584A Substituted aminoalkylidenamino triazines as herbicides
05/09/2001CN1294581A Pyridine derivative and pharmaceutical contg. same
05/09/2001CN1065529C 4-quinolinone derivative or salt thereof
05/08/2001US6228942 Dehydration to esterify or amidate surface of oxidized or aminated carbon powder or fiber suspended in solution containing a monomer or polymer having amine, hydroxy, and/or viny ether groups
05/08/2001US6228881 Aromatic heterocyclic compounds and their use as anti-inflammatory agents
05/08/2001US6228876 Administering 1-(1,3-dioxolan-2-ylmethy)l- or 1-(1,3-dioxan-2-ylmethyl)-1h-1,2,4-triazole derivative
05/08/2001US6228865 Compounds useful for inhibition of farnesyl protein transferase
05/08/2001US6228848 3-(1-propen-3-oxo)-5,6-dihydronaphthalene derivatives; side effect reduction
05/08/2001US6228808 Carbamoylphenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
05/08/2001CA2027530C W-phenoxy-heterocyclic compounds
05/03/2001WO2001030795A1 Hygromycin derivatives
05/03/2001WO2001030791A2 Method for the preparation of 2',3'-didehydro-2',3'-dideoxycytidine derivatives
05/03/2001WO2001030775A1 Novel indole compounds
05/03/2001WO2001030768A1 Methods and compositions utilizing quinazolinones
05/03/2001WO2001030766A1 Phthalazinone derivatives as pde 4 inhibitors
05/03/2001WO2001030762A1 Imidazol-4-ylmethanols use as inhibitors of steroid c17-20 lyase
05/03/2001WO2001030752A2 Indole compounds for treating bacterial infections
05/03/2001WO2001030749A1 Novel compounds
05/03/2001WO2001030349A1 Amorphous paroxetine compositon
05/03/2001WO2001030330A2 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
05/03/2001WO2001030148A1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
05/03/2001WO2001012607A3 Pharmaceutical compositions comprising 4-quinolones for treating cancers
05/03/2001DE19952147A1 Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung New cyclopropanes, pharmaceutical compositions containing them and methods for their preparation
05/03/2001CA2389191A1 Hygromycin derivatives
05/03/2001CA2388121A1 Phthalazinone derivatives as pde 4 inhibitors
05/03/2001CA2387869A1 Imidazol-4-ylmethanols use as inhibitors of steroid c17-20 lyase
05/03/2001CA2386441A1 Method to treat pain utilizing benzimidazole nmda/nr2b antagonists
05/02/2001EP1095939A2 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds
05/02/2001EP1095935A1 6-Hydroxy-5,6-dihydrouracils as herbicides
05/02/2001EP1095275A2 Endogenous constitutively activated g protein-coupled orphan receptors
05/02/2001EP1095039A2 New pharmaceutically active compounds
05/02/2001EP1095028A1 Substituted acylamino phenyl uracils
05/02/2001EP1095026A1 Pharmaceutical agents
05/02/2001EP1095020A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
05/02/2001EP1094813A2 Use of piperine for treating skin pigmentation disorders
05/02/2001EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
05/02/2001EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
05/02/2001EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/02/2001EP0769947B1 Indolinone compounds for the treatment of disease
05/02/2001CN1293663A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamix acids as matrix metal-protease
05/02/2001CN1293193A Preparation of piperidyl amino methyl trifluoro methyl cyclo other compounds
05/01/2001US6225479 Optically active bis-dioxane derivatives
05/01/2001US6225478 Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
05/01/2001US6225473 Reacting 1-methylpiperidin-4-one hydrobromide with bromine; reacting with 1,3,5-trimethoxybenzene; reacting solid with water to produce 3(r,s)-hydroxy-1-methyl-4-(2,4,6-trimethoxy-phenyl)-1,2,3,6-te
05/01/2001US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection